Oxolinic acid
From Infogalactic: the planetary knowledge core
File:Oxolinic acid.png | |
Systematic (IUPAC) name | |
---|---|
5-Ethyl-8-oxo-5,8-dihydro[1,3]dioxolo[4,5-g]quinoline- 7-carboxylic acid
|
|
Clinical data | |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
CAS Number | 14698-29-4 ![]() |
ATC code | J01MB05 (WHO) |
PubChem | CID: 4628 |
ChemSpider | 4467 ![]() |
UNII | L0A22B22FT ![]() |
KEGG | D02301 ![]() |
ChEBI | CHEBI:138856 ![]() |
ChEMBL | CHEMBL416755 ![]() |
Chemical data | |
Formula | C13H11NO5 |
Molecular mass | 261.23 g/mol |
|
|
|
|
![]() ![]() |
Oxolinic acid is a quinolone antibiotic developed in Japan in the 1970s.[1][2] Dosages 12–20 mg/kg orally administered for five to ten days. The antibiotic works by inhibiting the enzyme DNA gyrase. It also acts as a dopamine reuptake inhibitor and has stimulant effects in mice.[3]
See also
References
<templatestyles src="Asbox/styles.css"></templatestyles>
Categories:
- Pages with broken file links
- Chemical articles having calculated molecular weight overwritten
- Articles with changed InChI identifier
- Infobox drug articles without a structure image
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Quinolone antibiotics
- Benzodioxoles
- Dopamine reuptake inhibitors
- Antibiotic stubs